Coronary risk factor status after percutaneous transluminal coronary angioplasty

To determine whether patients modify their risk factors after undergoing percutaneous transluminal coronary angioplasty (PTCA).One-group, pretest-posttest. Pretest data were collected on the day before PTCA, and posttest data were collected at a mean follow-up of 11 months after PTCA. Data were collected from medical records and by patient self-report.University-affiliated, metropolitan public and private hospitals.Two hundred nine patients undergoing PTCA.Patients' smoking and exercise habits were assessed by self-report. Serum cholesterol level and body mass index were determined from entries in medical charts.All measured risk factors, with the exception of smoking, underwent favorable change (p < 0.001) after PTCA. The number of current smokers, however, increased significantly (p < 0.001), as did the number of cigarettes these patients smoked per day (p < 0.05).Evaluation of the effect of intervention strategies on reducing patients' smoking behavior after PTCA is required

Percutaneous transluminal coronary angioplasty: clinical and quality of life outcomes one year later.

Background: The quality of life status of patients prior to and following percutaneous transluminal coronary angioplasty (PTCA) has not been comprehensively investigated. Aim: This study was carried out to determine the effect that PTCA has on patients' quality of life. Methods: Data on 209 patients were collected one day pre‐PTCA and at a mean of two and 11 months post‐PTCA. Data on symptomatic status, functional capacity, life satisfaction and psychological well‐being were analysed quantitatively. Clinical outcomes, patient perception of PTCA and employment status wee analysed by descriptive statistics. Results: Highly significant improvement in all quality of life measures was found at the early follow‐up (p < .001). This improvement was sustained at the late follow‐up. At the late follow‐up, 58% of patients felt that PTCA had been very beneficial to their health and well‐being, and 79% of workers had returned to work. PTCA was primarily successful in 91% of vessels dilated. There were no procedural‐related deaths, 12 patients (6%) developed acute occlusion and three patients (1.5%) experienced myocardial infarction (MI). A symptomatic restenosis rate of 16% was found, including 19 patients (9%) requiring repeat PTCA and 14 (7%) undergoing coronary artery bypass grafting (CABG). Conclusion: These findings suggest that, after PTCA, the majority of patients experienced improved quality of life which was sustained one year later

Clinical results and quality of life after percutaneous transluminal coronary angioplasty: A preliminary report

To evaluate the effect of percutaneous transluminal coronary angioplasty (PTCA) on quality of life, data on symptomatic status, functional capacity, life satisfaction, and psychological wellness were collected on 102 patients at 1 day pre‐PTCA and 2 months post‐PTCA, and on the first 50 of these patients at 10 months post‐PTCA. There were highly significant changes (